Cereno will partner with PHA Europe & Global on patient-centered drug design for pulmonary hypertension medications.
Camp del Corazon and others are made for children with complex health conditions, writes columnist Jolie Lizana.
Living with PH and transplant often involves a lack of privacy, but columnist Anna Jeter has found ways to preserve her ...
Tectonic sees top-line results from a Phase 2 trial of TX45 in PH with heart failure with preserved ejection fraction by ...
Mannkind and United Therapeutics are creating an inhaled formulation of ralinepag, an experimental oral PAH treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results